Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma

Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Clin Mol Hepatol. 2025;31(3):914-934. Published online February 6, 2025

DOI: https://doi.org/10.3350/cmh.2024.1038

View: 3442 Download: 856 Crossref: 2

Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma

Jiwon Hong, Jung Woo Eun, Geum Ok Baek, Jae Youn Cheong, Seryoung Park, Soon Sun Kim, Hyo Jung Cho, Su Bin Lim

Clin Mol Hepatol. 2024;30(3):360-374. Published online March 15, 2024

DOI: https://doi.org/10.3350/cmh.2024.0042

View: 6010 Download: 366 Web of Science: 3 Crossref: 4

Correspondence

Correspondence: Response to the Letter Regarding "GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma"

Hyung Seok Kim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received March 12, 2025 Accepted March 15, 2025

DOI: https://doi.org/10.3350/cmh.2025.0287 [Accepted]

PDF

View: 503 Download: 27

Correspondence: Response to Editorial on “GULP1, a Multifaceted Biomarker and Therapeutic Target in HCC”

Soon Sun Kim, Hyung Seok Kim, Jae Youn Cheong, Jung Woo Eun

Received March 28, 2025 Accepted April 2, 2025

DOI: https://doi.org/10.3350/cmh.2025.0350 [Accepted]

PDF

View: 338 Download: 11

Editorial

Uncovering the MET-TRIB3-FOXO1 axis: A Novel Target in MET-driven Hepatocellular Carcinoma

Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received May 9, 2025 Accepted May 13, 2025

DOI: https://doi.org/10.3350/cmh.2025.0515 [Accepted]

PDF

View: 474 Download: 44

Reply to Correspondence

Reply to correspondence on “MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation”

Ji Eun Han, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun

Received May 26, 2025 Accepted May 30, 2025

DOI: https://doi.org/10.3350/cmh.2025.0564 [Accepted]

PDF

View: 297 Download: 11

Viewed By 12321	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7544	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 6978	MAFLD: How is it different from NAFLD?
Viewed By 5611	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5436	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 366	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 348	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Author :

Author index